CompletedPhase 3

Conservative Pulp Therapy of Primary Molars Using TheraCAL

Egypt216 participantsStarted 2019-11-25

Plain-language summary

The study is a clinical trial that assesses the clinical and radiographic success rates of 3 conservative pulp therapy treatments in primary molars compared to conventional pulpotomy using a bioactive dual cured calcium silicate cement (TheraCAL PT).

Who can participate

Age range4 Years – 6 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Four to six years old healthy children * Cooperative (frankle scale + and ++) * With at least one vital and restorable primary molar with deep caries. Exclusion Criteria: * History of spontaneous pain, swelling, or sinus tract * Pathological mobility * pain on percussion * Furcation or periapical radiolucency * Internal or external pathological root resorption * Widening of periodontal membrane space * Discontinuity of lamina dura.

What they're measuring

Changes in Visual and tactile clinical examination

Timeframe: every 6 months

Trial details

NCT IDNCT04167943

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-08-01

View on ClinicalTrials.gov More Reversible Pulpitis trials